Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We investigated the functional impact of a recently described islet-specific loss of sympathetic nerves that occurs soon after the autoimmune destruction of β-cells in the BB diabetic rat ( 35 ). We found that the portal venous (PV) glucagon response to sympathetic nerve stimulation (SNS) was markedly impaired in newly diabetic BB rats (BB D). We next found a normal glucagon response to intravenous epinephrine in BB D, eliminating the possibility of a generalized secretory defect of the BB D α-cell as the mediator of the impaired glucagon response to SNS. We then sought to determine whether the glucagon impairment to SNS in BB D was due solely to their loss of islet sympathetic nerve terminals or whether other effects of autoimmune diabetes contributed. We therefore reproduced, in nondiabetic Wistar rats, an islet nerve terminal loss similar to that in BB D with systemic administration of the sympathetic neurotoxin 6-hydroxydopamine. The impairment of the glucagon response to SNS in these chemically denervated, nondiabetic rats was similar to that in the spontaneously denervated BB D. We conclude that the early sympathetic islet neuropathy of BB D causes a functional defect of the sympathetic pathway to the α-cell that can, by itself, account for the impaired glucagon response to postganglionic SNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688 · cited 2×
“Human autoimmune type 1 diabetes is characterized by a major impairment of the glucagon response to insulin-induced hypoglycemia (2) which is evident early in the course of the disease (3).”
BackgroundHeller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152 · cited 1×
“Third, the brain’s sensitivity to hypoglycemia, and thus the magnitude of sympathetic outflow from the brain, can be impaired by repetitive iatrogenic hypoglycemia, a phenomenon termed hypoglycemia-associated autonomic failure (8, 9, 23).”
BackgroundFukuda, M., Tanaka, A., Tahara, Y., Ikegami, H., Yamamoto, Y., Kumahara, Y., & Shima, K. (1988) · Diabetes · doi:10.2337/diab.37.1.81 · Cited by 145
Counterregulatory adaptation to recurrent hypoglycemia in normal humans
DAVIS, M. R., & SHAMOON, H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-995 · Cited by 143
Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans
Esler, M. D., Wallin, G., Dorward, P. K., Eisenhofer, G., Westerman, R., Meredith, I., Lambert, G., Cox, H. S., & Jennings, G. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.4.r817 · Cited by 124
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Greenbaum, C. J., Havel, P. J., Taborsky, G. J., & Klaff, L. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115375 · Cited by 106 · cited 1×
“In addition, diabetic hyperglycemia is unlikely to account for the markedly impaired glucagon response we observed during SNS, since the glucagon response to the low dose of epinephrine was not suppressed in hyperglycemic BB D and since our previous work showed that the ability of hyperglycemia to suppress glucagon se…”
BackgroundSelf-citationNeuropathology of the oesophagus in diabetes mellitus
Smith, B. (1974) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.10.1151 · Cited by 80 · cited 1×
“Diabetic autonomic neuropathy (DAN), a wellknown complication of type 1 diabetes, impairs several classes of nerves (3, 11, 43), including peripheral sympathetic nerves (31, 45).”
Background
Cited by
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Taborsky, G. J., & Mundinger, T. O. (2012) · Endocrinology · doi:10.1210/en.2011-2040 · Cited by 140
“Neither -cell loss nor hyperglycemia causes eSIN because islet sympathetic nerves are not lost in chemically induced diabetes (25, 27).”
BackgroundSelf-citationThe physiology and pathophysiology of the neural control of the counterregulatory response
Beall, C., Ashford, M. L., & McCrimmon, R. J. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00531.2011 · Cited by 63
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Metadata
- Authors
- Mundinger, T. O., Mei, Q., Figlewicz, D. P., Lernmark, Å., & Taborsky, G. J.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2003-11
- Volume
- 285
- Issue
- 5
- Pages
- E1047-E1054
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2132186511
- Cited by
- 36
- References
- 9
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. https://app.cochat.ai/papers/10.1152/ajpendo.00136.2003
- The paper
- Mundinger, T. O., Mei, Q., Figlewicz, D. P., Lernmark, Å., & Taborsky, G. J. (2003). Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00136.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.